Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

297 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessment of long-term rectal function in patients who received pelvic radiotherapy: a pooled North Central Cancer Treatment Group trial analysis, N09C1.
Brown LC, Atherton PJ, Neben-Wittich MA, Wender DB, Behrens RJ, Kozelsky TF, Loprinzi CL, Haddock MG, Martenson JA. Brown LC, et al. Among authors: atherton pj. Support Care Cancer. 2013 Oct;21(10):2869-77. doi: 10.1007/s00520-013-1853-0. Epub 2013 Jun 8. Support Care Cancer. 2013. PMID: 23748483 Free PMC article.
Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: a randomized controlled trial.
Rummans TA, Clark MM, Sloan JA, Frost MH, Bostwick JM, Atherton PJ, Johnson ME, Gamble G, Richardson J, Brown P, Martensen J, Miller J, Piderman K, Huschka M, Girardi J, Hanson J. Rummans TA, et al. Among authors: atherton pj. J Clin Oncol. 2006 Feb 1;24(4):635-42. doi: 10.1200/JCO.2006.06.209. J Clin Oncol. 2006. PMID: 16446335 Clinical Trial.
Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4).
Halyard MY, Jatoi A, Sloan JA, Bearden JD 3rd, Vora SA, Atherton PJ, Perez EA, Soori G, Zalduendo AC, Zhu A, Stella PJ, Loprinzi CL. Halyard MY, et al. Among authors: atherton pj. Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1318-22. doi: 10.1016/j.ijrobp.2006.10.046. Int J Radiat Oncol Biol Phys. 2007. PMID: 17394940 Clinical Trial.
Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3.
Barton DL, Wender DB, Sloan JA, Dalton RJ, Balcueva EP, Atherton PJ, Bernath AM Jr, DeKrey WL, Larson T, Bearden JD 3rd, Carpenter PC, Loprinzi CL. Barton DL, et al. Among authors: atherton pj. J Natl Cancer Inst. 2007 May 2;99(9):672-9. doi: 10.1093/jnci/djk149. J Natl Cancer Inst. 2007. PMID: 17470735 Clinical Trial.
Measuring spiritual quality of life in patients with cancer.
Johnson ME, Piderman KM, Sloan JA, Huschka M, Atherton PJ, Hanson JM, Brown PD, Rummans TA, Clark MM, Frost MH. Johnson ME, et al. Among authors: atherton pj. J Support Oncol. 2007 Oct;5(9):437-42. J Support Oncol. 2007. PMID: 18019851
Dehydroepiandrosterone for the treatment of hot flashes: a pilot study.
Barton DL, Loprinzi C, Atherton PJ, Kottschade L, Collins M, Carpenter P, Adjei A, Rummans TA, Shanafelt T, Christensen B, Sloan J. Barton DL, et al. Among authors: atherton pj. Support Cancer Ther. 2006 Jan 1;3(2):91-7. doi: 10.3816/SCT.2006.n.004. Support Cancer Ther. 2006. PMID: 18632445
Pilot evaluation of aprepitant for the treatment of hot flashes.
Bardia A, Thompson S, Atherton PJ, Barton DL, Sloan JA, Kottschade LA, Christensen B, Collins M, Loprinzi CL. Bardia A, et al. Among authors: atherton pj. Support Cancer Ther. 2006 Jul 1;3(4):240-6. doi: 10.3816/SCT.2006.n.022. Support Cancer Ther. 2006. PMID: 18632500
Phase II Evaluation of Desipramine for the Treatment of Hot Flashes.
Barton DL, Loprinzi CL, Atherton P, Raymond J, Shanafelt T, Hines S, Palmieri F, Rummans T, Adjei AA, Sloan J. Barton DL, et al. Support Cancer Ther. 2007 Sep 1;4(4):219-24. doi: 10.3816/SCT.2007.n.018. Support Cancer Ther. 2007. PMID: 18632520
Phase III, double-blind study of depot octreotide versus placebo in the prevention of acute diarrhea in patients receiving pelvic radiation therapy: results of North Central Cancer Treatment Group N00CA.
Martenson JA, Halyard MY, Sloan JA, Proulx GM, Miller RC, Deming RL, Dick SJ, Johnson HA, Tai TH, Zhu AW, Keit J, Stien KJ, Atherton PJ. Martenson JA, et al. Among authors: atherton pj. J Clin Oncol. 2008 Nov 10;26(32):5248-53. doi: 10.1200/JCO.2008.17.1546. Epub 2008 Sep 2. J Clin Oncol. 2008. PMID: 18768432 Free PMC article. Clinical Trial.
Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer.
Hines SL, Mincey BA, Sloan JA, Thomas SP, Chottiner E, Loprinzi CL, Carlson MD, Atherton PJ, Salim M, Perez EA. Hines SL, et al. Among authors: atherton pj. J Clin Oncol. 2009 Mar 1;27(7):1047-53. doi: 10.1200/JCO.2008.19.1783. Epub 2008 Dec 15. J Clin Oncol. 2009. PMID: 19075260 Free PMC article. Clinical Trial.
297 results